The website is currently being updated.
We apologize for any inconvenience.
Vol. 16 No. 3 (2023)
- Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma
- Nivo-BeGEV as Preparation for Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Study
- Mutation Profile of Normal and Tumor Cells in a Patient with Multiple Myeloma: A Case Report
Published:
09.06.2023



